Nordic Cannabis Cultivation Market Size & Outlook, 2026-2034

Nordic Cannabis Cultivation Market Insights

Deep Market Insights analysis indicates that the Nordic Cannabis Cultivation Market size, valued at USD 282.79 Million in 2025, is expected to expand to USD 734.96 Million by 2034.
The Nordic market is forecasted to expand at a CAGR of 11.27% spanning 2026–2034.
Medical cannabis held the leading position among By Type segments in 2025, based on market size.
CBD-rich cannabis is projected to post the fastest growth rate, sustaining its position as the most attractive By Type segment during the forecast horizon.

Nordic accounted for 1.1% of the global Cannabis Cultivation Market size in 2025.
By 2034, United States is expected to remain the top global market in terms of size.
Within Europe, Germany is forecasted to dominate the regional Cannabis Cultivation Market size by 2034.
Italy will be the fastest-growing market in Europe, projected to achieve USD 1513.72 Million by 2034.

Report Scope	Details
Base Year for Study	2025
Study Period	2022-2034
Historical Period	2022-2024
Forecast Period	2026-2034
Market Size In 2025	USD 282.79 Million
Market Size In 2034	USD 734.96 Million
Largest segment	Medical cannabis
Units	Revenue in USD Million
CAGR	11.27% (2026-2034)
Segmnetation Covered
By Type	Medical cannabis Industrial hemp Recreational cannabis CBD-rich cannabis
By Cultivation Method	Indoor cultivation Outdoor cultivation Greenhouse cultivation Hydroponic cultivation
By Application	Pharmaceuticals Recreational use Food & beverages Cosmetics
By End User	Commercial growers Research institutions Pharmaceutical companies Consumers
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

By Type	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Medical cannabis	XX.x	XX.x	XX.x	113.54	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Industrial hemp	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Recreational cannabis	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
CBD-rich cannabis	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Cultivation Method	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Indoor cultivation	XX.x	XX.x	XX.x	128.27	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Outdoor cultivation	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Greenhouse cultivation	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Hydroponic cultivation	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By Application	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Pharmaceuticals	XX.x	XX.x	XX.x	139.67	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Recreational use	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Food & beverages	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Cosmetics	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x

Source: DMI Analysis Company Publications, Primary Interviews.

By End User	2022	2023	2024	2025	2026	2027	2028	2029	2030	2031	2032	2033	2034
Commercial growers	XX.x	XX.x	XX.x	113.54	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Research institutions	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Pharmaceutical companies	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Consumers	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x
Total	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x	XX.x